
E134: Brepocitinib in Dermatomyositis (VALOR)
Apr 17, 2026 - 14:58
Radio and PodcastLive Radio & Podcasts
Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises some interesting questions about what worked here and whether or not it matters h...
E135: IL17 and a GLP1? is an episode from The Evidence Based Rheumatology Podcast by Michael Putman. Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises...
This episode belongs to The Evidence Based Rheumatology Podcast.
Use the player on this page to stream the episode online.
Published Apr 30, 2026, 11:03 long, audio available.
Really interesting study this week comparing the IL17 inhibitor ixekizumab WITH the GLP1 inhibitor tirzepatide to ixekizumab alone. Raises some interesting questions about what worked here and whether or not it matters how it worked. Paper: Newsletter:
You can listen to E135: IL17 and a GLP1? online on Radio and Podcast. Open the player on this page to stream the available audio.
E135: IL17 and a GLP1? is an episode from The Evidence Based Rheumatology Podcast by Michael Putman.
This episode is 11:03 long.
This episode was published on Apr 30, 2026.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from The Evidence Based Rheumatology Podcast when more episodes are available from the podcast feed.
You can listen to E135: IL17 and a GLP1? on this page when the episode audio is available from the podcast feed.
E135: IL17 and a GLP1? is from The Evidence Based Rheumatology Podcast by Michael Putman.
Published Apr 30, 2026 and 11:03 long